Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Irofulven in Treating Children With Recurrent or Refractory Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: February 4, 2013
Last verified: May 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)